Concepedia

Rémy Gressin

RG

90

Publications

7.2K

Citations

41

H-Index

1991

Active since

Affiliations

Centre Hospitalier Universitaire de Grenoble(Current)

Inserm

Centre Hospitalier Universitaire de Tours

Université Grenoble Alpes

Centre National de la Recherche Scientifique

Rémy Gressin is an author at Centre Hospitalier Universitaire de Grenoble specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1991–2024

90

Publications

90

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill, Catherine Thiéblemont, Lucie Obéric et al. · New England Journal of Medicine · 2017 · 398 citations · Full text

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas

Olivier Manches, Gabrielle Lui, Laurence Chaperot et al. · Blood · 2003 · 358 citations · Full text

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

Nöel Milpied, Éric Deconinck, Fanny Gaillard et al. · New England Journal of Medicine · 2004 · 341 citations · Full text

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Carole Soussain, Sylvain Choquet, Marie Blonski et al. · European Journal of Cancer · 2019 · 305 citations · Full text

, , +6

Rows per page

1–5 of 90